217 related articles for article (PubMed ID: 26406334)
1. Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study.
Kim B; Cheon JH; Moon HJ; Park YR; Ye BD; Yang SK; Seo GS; Jang BI; Kim YS; Kim JS; Han DS; Kim YH; Kim WH
J Gastroenterol Hepatol; 2016 Jan; 31(1):126-32. PubMed ID: 26406334
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
[TBL] [Abstract][Full Text] [Related]
3. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
Abraham NS; Richardson P; Castillo D; Kane SV
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
[TBL] [Abstract][Full Text] [Related]
4. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298
[TBL] [Abstract][Full Text] [Related]
5. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.
Drobne D; Bossuyt P; Breynaert C; Cattaert T; Vande Casteele N; Compernolle G; Jürgens M; Ferrante M; Ballet V; Wollants WJ; Cleynen I; Van Steen K; Gils A; Rutgeerts P; Vermeire S; Van Assche G
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):514-521.e4. PubMed ID: 25066841
[TBL] [Abstract][Full Text] [Related]
7. Prior use of immunomodulatory drugs improves the clinical outcome of endoscopic balloon dilation for intestinal stricture in patients with Crohn's disease.
Honzawa Y; Nakase H; Matsuura M; Higuchi H; Toyonaga T; Matsumura K; Yoshino T; Okazaki K; Chiba T
Dig Endosc; 2013 Sep; 25(5):535-43. PubMed ID: 23363364
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease.
Grossi V; Lerer T; Griffiths A; LeLeiko N; Cabrera J; Otley A; Rick J; Mack D; Bousvaros A; Rosh J; Grossman A; Saeed S; Kay M; Boyle B; Oliva-Hemker M; Keljo D; Pfefferkorn M; Faubion W; Kappelman MD; Sudel B; Markowitz J; Hyams JS
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1748-56. PubMed ID: 25911120
[TBL] [Abstract][Full Text] [Related]
9. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.
Niewiadomski O; Studd C; Hair C; Wilson J; Ding NS; Heerasing N; Ting A; McNeill J; Knight R; Santamaria J; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Popp B; Connell W; Desmond P; Bell S
J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770
[TBL] [Abstract][Full Text] [Related]
10. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
Ramadas AV; Gunesh S; Thomas GA; Williams GT; Hawthorne AB
Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
[TBL] [Abstract][Full Text] [Related]
11. Surgery, Crohn's disease, and the biological era: has there been an impact?
Slattery E; Keegan D; Hyland J; O'donoghue D; Mulcahy HE
J Clin Gastroenterol; 2011 Sep; 45(8):691-3. PubMed ID: 21135702
[TBL] [Abstract][Full Text] [Related]
12. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of early immunomodulator therapy on the outcomes of Crohn's disease.
Kwak MS; Kim DH; Park SJ; Kim TI; Hong SP; Kim WH; Cheon JH
BMC Gastroenterol; 2014 May; 14():85. PubMed ID: 24886458
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
17. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
[TBL] [Abstract][Full Text] [Related]
18. The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963-2005.
Zhulina Y; Udumyan R; Tysk C; Montgomery S; Halfvarson J
Scand J Gastroenterol; 2016 Mar; 51(3):304-13. PubMed ID: 26448101
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
[TBL] [Abstract][Full Text] [Related]
20. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study.
Feagan BG; Panaccione R; Sandborn WJ; D'Haens GR; Schreiber S; Rutgeerts PJ; Loftus EV; Lomax KG; Yu AP; Wu EQ; Chao J; Mulani P
Gastroenterology; 2008 Nov; 135(5):1493-9. PubMed ID: 18848553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
